UMIN ID: C000000297
Registered date:16/12/2005
Study on Diagnosis of early Alzheimer's disease-Japan
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Mild Cognitive Impairment |
| Date of first enrollment | 2005/12/01 |
| Target sample size | 150 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Alzheimer's disease |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 79years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | History of alcohol abuse or dependency History of epilepsy Years of schooling <=6 No study partner Diabetes mellitus under insulin treatment Specific psychoactive medications (for example, certain antidepressants, anti-anxiety medications, sleeping pills, etc.) Donepezil hydrochloride within the past one month before PET study Critical complication |
Related Information
| Primary Sponsor | Department of Brain Science and Molecular Imaging National Institute for Longevity Sciences National Center for Geriatrics and Gerontology |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kengo Ito |
| Address | 36-3, Gengo Morioka-cho, Obu-shi, Aichi, 474-8522, Japan Japan |
| Telephone | 0562-46-2311 |
| kito@ncgg.go.jp | |
| Affiliation | National Center for Geriatrics and Gerontology Department of Brain Science and Molecular Imaging, National Institute for Longevity Sciences |
| scientific contact | |
| Name | Kengo Ito |
| Address | 36-3, Gengo Morioka-cho, Obu-shi, Aichi, 474-8522, Japan Japan |
| Telephone | 0562-46-2311 |
| kito@ncgg.go.jp | |
| Affiliation | National Center for Geriatrics and Gerontology Department of Brain Science and Molecular Imaging, National Institute for Longevity Sciences |